nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—VEGFA—sarcoma	0.673	1	CbGaD
Minocycline—IL1B—knee—sarcoma	0.00841	0.0573	CbGeAlD
Minocycline—IL1B—dermis—sarcoma	0.00699	0.0476	CbGeAlD
Minocycline—MMP9—dermis—sarcoma	0.00582	0.0397	CbGeAlD
Minocycline—IL1B—periosteum—sarcoma	0.00578	0.0394	CbGeAlD
Minocycline—MMP9—periosteum—sarcoma	0.00482	0.0329	CbGeAlD
Minocycline—IL1B—leg—sarcoma	0.00461	0.0314	CbGeAlD
Minocycline—IL1B—forelimb—sarcoma	0.00458	0.0312	CbGeAlD
Minocycline—CASP3—appendage—sarcoma	0.00442	0.0302	CbGeAlD
Minocycline—IL1B—hindlimb—sarcoma	0.00412	0.0281	CbGeAlD
Minocycline—IL1B—cartilage tissue—sarcoma	0.00405	0.0276	CbGeAlD
Minocycline—IL1B—appendage—sarcoma	0.00353	0.0241	CbGeAlD
Minocycline—MMP9—hindlimb—sarcoma	0.00343	0.0234	CbGeAlD
Minocycline—MMP9—cartilage tissue—sarcoma	0.00338	0.023	CbGeAlD
Minocycline—MMP9—appendage—sarcoma	0.00294	0.0201	CbGeAlD
Minocycline—CASP3—endothelium—sarcoma	0.00267	0.0182	CbGeAlD
Minocycline—IL1B—endothelium—sarcoma	0.00213	0.0145	CbGeAlD
Minocycline—CASP1—myometrium—sarcoma	0.00185	0.0126	CbGeAlD
Minocycline—MMP9—endothelium—sarcoma	0.00178	0.0121	CbGeAlD
Minocycline—CYCS—embryo—sarcoma	0.00171	0.0117	CbGeAlD
Minocycline—CASP1—seminal vesicle—sarcoma	0.00167	0.0114	CbGeAlD
Minocycline—CASP1—hematopoietic system—sarcoma	0.00159	0.0108	CbGeAlD
Minocycline—CASP1—connective tissue—sarcoma	0.00153	0.0104	CbGeAlD
Minocycline—CYCS—hematopoietic system—sarcoma	0.00153	0.0104	CbGeAlD
Minocycline—CASP3—myometrium—sarcoma	0.00153	0.0104	CbGeAlD
Minocycline—CYCS—connective tissue—sarcoma	0.00147	0.01	CbGeAlD
Minocycline—CASP3—embryo—sarcoma	0.00147	0.01	CbGeAlD
Minocycline—CASP1—skin of body—sarcoma	0.00138	0.00943	CbGeAlD
Minocycline—CASP3—seminal vesicle—sarcoma	0.00138	0.00941	CbGeAlD
Minocycline—CYCS—smooth muscle tissue—sarcoma	0.00135	0.00919	CbGeAlD
Minocycline—CYCS—skin of body—sarcoma	0.00133	0.00907	CbGeAlD
Minocycline—CASP3—hematopoietic system—sarcoma	0.00131	0.00894	CbGeAlD
Minocycline—CASP3—connective tissue—sarcoma	0.00126	0.00861	CbGeAlD
Minocycline—IL1B—myometrium—sarcoma	0.00122	0.00832	CbGeAlD
Minocycline—CASP1—uterus—sarcoma	0.0012	0.00819	CbGeAlD
Minocycline—VEGFA—myometrium—sarcoma	0.0012	0.00818	CbGeAlD
Minocycline—IL1B—embryo—sarcoma	0.00117	0.008	CbGeAlD
Minocycline—CYCS—uterus—sarcoma	0.00116	0.00788	CbGeAlD
Minocycline—CASP3—smooth muscle tissue—sarcoma	0.00115	0.00787	CbGeAlD
Minocycline—CASP3—skin of body—sarcoma	0.00114	0.00777	CbGeAlD
Minocycline—CASP1—lymphoid tissue—sarcoma	0.00112	0.00763	CbGeAlD
Minocycline—CYCS—lymphoid tissue—sarcoma	0.00108	0.00735	CbGeAlD
Minocycline—CASP1—tendon—sarcoma	0.00105	0.00718	CbGeAlD
Minocycline—IL1B—hematopoietic system—sarcoma	0.00105	0.00714	CbGeAlD
Minocycline—CASP1—bone marrow—sarcoma	0.00102	0.00695	CbGeAlD
Minocycline—IL1B—connective tissue—sarcoma	0.00101	0.00688	CbGeAlD
Minocycline—CASP3—uterus—sarcoma	0.00099	0.00675	CbGeAlD
Minocycline—CYCS—bone marrow—sarcoma	0.000981	0.00669	CbGeAlD
Minocycline—MMP9—embryo—sarcoma	0.000978	0.00667	CbGeAlD
Minocycline—CASP3—lymphoid tissue—sarcoma	0.000923	0.00629	CbGeAlD
Minocycline—IL1B—smooth muscle tissue—sarcoma	0.000922	0.00629	CbGeAlD
Minocycline—IL1B—skin of body—sarcoma	0.000911	0.00621	CbGeAlD
Minocycline—VEGFA—smooth muscle tissue—sarcoma	0.000907	0.00619	CbGeAlD
Minocycline—MMP9—hematopoietic system—sarcoma	0.000873	0.00595	CbGeAlD
Minocycline—CASP1—testis—sarcoma	0.000871	0.00594	CbGeAlD
Minocycline—CASP3—tendon—sarcoma	0.000868	0.00592	CbGeAlD
Minocycline—CASP3—bone marrow—sarcoma	0.00084	0.00573	CbGeAlD
Minocycline—MMP9—connective tissue—sarcoma	0.00084	0.00573	CbGeAlD
Minocycline—CYCS—testis—sarcoma	0.000839	0.00572	CbGeAlD
Minocycline—CASP1—liver—sarcoma	0.000824	0.00562	CbGeAlD
Minocycline—CYCS—liver—sarcoma	0.000793	0.00541	CbGeAlD
Minocycline—IL1B—uterus—sarcoma	0.000791	0.00539	CbGeAlD
Minocycline—VEGFA—cardiac atrium—sarcoma	0.000782	0.00533	CbGeAlD
Minocycline—VEGFA—uterus—sarcoma	0.000778	0.00531	CbGeAlD
Minocycline—MMP9—smooth muscle tissue—sarcoma	0.000769	0.00524	CbGeAlD
Minocycline—MMP9—skin of body—sarcoma	0.000759	0.00517	CbGeAlD
Minocycline—IL1B—lymphoid tissue—sarcoma	0.000737	0.00503	CbGeAlD
Minocycline—CASP3—testis—sarcoma	0.000718	0.0049	CbGeAlD
Minocycline—IL1B—tendon—sarcoma	0.000693	0.00473	CbGeAlD
Minocycline—ALOX5—hematopoietic system—sarcoma	0.00069	0.00471	CbGeAlD
Minocycline—VEGFA—tendon—sarcoma	0.000682	0.00465	CbGeAlD
Minocycline—CASP3—liver—sarcoma	0.000679	0.00463	CbGeAlD
Minocycline—IL1B—bone marrow—sarcoma	0.000671	0.00458	CbGeAlD
Minocycline—ALOX5—connective tissue—sarcoma	0.000664	0.00453	CbGeAlD
Minocycline—VEGFA—bone marrow—sarcoma	0.00066	0.0045	CbGeAlD
Minocycline—MMP9—uterus—sarcoma	0.000659	0.0045	CbGeAlD
Minocycline—CASP1—lymph node—sarcoma	0.000632	0.00431	CbGeAlD
Minocycline—MMP9—lymphoid tissue—sarcoma	0.000614	0.00419	CbGeAlD
Minocycline—CYCS—lymph node—sarcoma	0.000608	0.00415	CbGeAlD
Minocycline—ALOX5—smooth muscle tissue—sarcoma	0.000608	0.00414	CbGeAlD
Minocycline—MMP9—tendon—sarcoma	0.000578	0.00394	CbGeAlD
Minocycline—IL1B—testis—sarcoma	0.000574	0.00391	CbGeAlD
Minocycline—VEGFA—testis—sarcoma	0.000565	0.00385	CbGeAlD
Minocycline—MMP9—bone marrow—sarcoma	0.000559	0.00382	CbGeAlD
Minocycline—IL1B—liver—sarcoma	0.000543	0.0037	CbGeAlD
Minocycline—VEGFA—liver—sarcoma	0.000534	0.00364	CbGeAlD
Minocycline—CASP3—lymph node—sarcoma	0.000521	0.00355	CbGeAlD
Minocycline—ALOX5—lymphoid tissue—sarcoma	0.000486	0.00331	CbGeAlD
Minocycline—MMP9—testis—sarcoma	0.000478	0.00326	CbGeAlD
Minocycline—SLC22A8—hematopoietic system—sarcoma	0.000467	0.00318	CbGeAlD
Minocycline—MMP9—liver—sarcoma	0.000452	0.00308	CbGeAlD
Minocycline—SLC22A7—testis—sarcoma	0.000443	0.00302	CbGeAlD
Minocycline—ALOX5—bone marrow—sarcoma	0.000442	0.00302	CbGeAlD
Minocycline—SLC22A11—liver—sarcoma	0.000429	0.00292	CbGeAlD
Minocycline—SLC22A7—liver—sarcoma	0.000418	0.00285	CbGeAlD
Minocycline—IL1B—lymph node—sarcoma	0.000416	0.00284	CbGeAlD
Minocycline—VEGFA—lymph node—sarcoma	0.000409	0.00279	CbGeAlD
Minocycline—ALOX5—testis—sarcoma	0.000378	0.00258	CbGeAlD
Minocycline—ALOX5—liver—sarcoma	0.000357	0.00244	CbGeAlD
Minocycline—MMP9—lymph node—sarcoma	0.000347	0.00236	CbGeAlD
Minocycline—ALOX5—lymph node—sarcoma	0.000274	0.00187	CbGeAlD
Minocycline—IL1B—MAPK Signaling Pathway—NRAS—sarcoma	9.31e-05	0.000516	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—SRC—sarcoma	9.25e-05	0.000512	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—KDR—sarcoma	9.14e-05	0.000507	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	9.02e-05	0.0005	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—MDM2—sarcoma	9e-05	0.000499	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—VEGFA—sarcoma	8.99e-05	0.000498	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—MDM2—sarcoma	8.96e-05	0.000497	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CREB1—sarcoma	8.95e-05	0.000496	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD34—sarcoma	8.94e-05	0.000496	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—NRAS—sarcoma	8.89e-05	0.000493	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—KRAS—sarcoma	8.85e-05	0.000491	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—MYC—sarcoma	8.82e-05	0.000489	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—SRC—sarcoma	8.73e-05	0.000484	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—MYC—sarcoma	8.67e-05	0.000481	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	8.65e-05	0.000479	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—EGFR—sarcoma	8.63e-05	0.000478	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—sarcoma	8.57e-05	0.000475	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—SRC—sarcoma	8.54e-05	0.000473	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—KRAS—sarcoma	8.52e-05	0.000472	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—HRAS—sarcoma	8.51e-05	0.000472	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—EGFR—sarcoma	8.48e-05	0.00047	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	8.46e-05	0.000469	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—NRAS—sarcoma	8.4e-05	0.000465	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—sarcoma	8.39e-05	0.000465	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—PTPRC—sarcoma	8.37e-05	0.000464	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—HRAS—sarcoma	8.31e-05	0.000461	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—NRAS—sarcoma	8.22e-05	0.000455	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—PLCG1—sarcoma	8.19e-05	0.000454	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PLCG1—sarcoma	8.03e-05	0.000445	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—KRAS—sarcoma	8.01e-05	0.000444	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	7.99e-05	0.000443	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ENO2—sarcoma	7.9e-05	0.000437	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—sarcoma	7.87e-05	0.000436	CbGpPWpGaD
Minocycline—CYCS—Metabolism—HBA1—sarcoma	7.85e-05	0.000435	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CCND1—sarcoma	7.84e-05	0.000434	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—JUN—sarcoma	7.82e-05	0.000434	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	7.76e-05	0.00043	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—KDR—sarcoma	7.76e-05	0.00043	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—KRAS—sarcoma	7.65e-05	0.000424	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—JUN—sarcoma	7.62e-05	0.000422	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CTNNB1—sarcoma	7.56e-05	0.000419	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—EGFR—sarcoma	7.49e-05	0.000415	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP2—sarcoma	7.46e-05	0.000413	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	7.46e-05	0.000413	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—MDM2—sarcoma	7.4e-05	0.00041	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL2—sarcoma	7.37e-05	0.000408	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—sarcoma	7.25e-05	0.000402	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HRAS—sarcoma	7.24e-05	0.000401	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—KRAS—sarcoma	7.23e-05	0.0004	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—HRAS—sarcoma	7.22e-05	0.0004	CbGpPWpGaD
Minocycline—CASP1—Immune System—FOXO1—sarcoma	7.18e-05	0.000398	CbGpPWpGaD
Minocycline—CASP1—Immune System—PDGFRB—sarcoma	7.17e-05	0.000397	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—sarcoma	7.12e-05	0.000395	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	7.1e-05	0.000394	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—KRAS—sarcoma	7.07e-05	0.000392	CbGpPWpGaD
Minocycline—CASP1—Immune System—PDGFRA—sarcoma	7.06e-05	0.000391	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—SRC—sarcoma	6.99e-05	0.000387	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TLE1—sarcoma	6.82e-05	0.000378	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—CREB1—sarcoma	6.8e-05	0.000377	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—sarcoma	6.79e-05	0.000376	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—KDR—sarcoma	6.74e-05	0.000373	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—NRAS—sarcoma	6.72e-05	0.000372	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PLCG1—sarcoma	6.7e-05	0.000371	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—FOXO1—sarcoma	6.69e-05	0.000371	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CCND1—sarcoma	6.52e-05	0.000362	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—JUN—sarcoma	6.51e-05	0.000361	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—HRAS—sarcoma	6.51e-05	0.000361	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	6.5e-05	0.00036	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	6.48e-05	0.000359	CbGpPWpGaD
Minocycline—IL1B—Immune System—PTPRC—sarcoma	6.47e-05	0.000358	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CTNNB1—sarcoma	6.46e-05	0.000358	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	6.43e-05	0.000357	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—JUN—sarcoma	6.43e-05	0.000356	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CTNNB1—sarcoma	6.38e-05	0.000354	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MMP2—sarcoma	6.33e-05	0.000351	CbGpPWpGaD
Minocycline—IL1B—Immune System—PLCG1—sarcoma	6.33e-05	0.000351	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—MYC—sarcoma	6.29e-05	0.000348	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—NRAS—sarcoma	6.19e-05	0.000343	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—EGFR—sarcoma	6.15e-05	0.000341	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—HRAS—sarcoma	6.14e-05	0.00034	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—EGFR—sarcoma	6.12e-05	0.000339	CbGpPWpGaD
Minocycline—IL1B—Immune System—ATF1—sarcoma	6.01e-05	0.000333	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—HRAS—sarcoma	6.01e-05	0.000333	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—IL2—sarcoma	5.93e-05	0.000329	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—CREB1—sarcoma	5.91e-05	0.000327	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—SRC—sarcoma	5.84e-05	0.000324	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	5.82e-05	0.000322	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—FOXO1—sarcoma	5.81e-05	0.000322	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—KRAS—sarcoma	5.81e-05	0.000322	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—KRAS—sarcoma	5.79e-05	0.000321	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—SRC—sarcoma	5.77e-05	0.00032	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—MDM2—sarcoma	5.76e-05	0.000319	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VEGFC—sarcoma	5.75e-05	0.000319	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—NRAS—sarcoma	5.55e-05	0.000308	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—KDR—sarcoma	5.54e-05	0.000307	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP2—sarcoma	5.5e-05	0.000305	CbGpPWpGaD
Minocycline—CASP1—Immune System—KIT—sarcoma	5.47e-05	0.000303	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—KRAS—sarcoma	5.33e-05	0.000295	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	5.21e-05	0.000289	CbGpPWpGaD
Minocycline—CASP1—Immune System—CREB1—sarcoma	5.21e-05	0.000289	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—SRC—sarcoma	5.17e-05	0.000287	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—sarcoma	5.16e-05	0.000286	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—EGFR—sarcoma	5.12e-05	0.000284	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	5.1e-05	0.000282	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—EGFR—sarcoma	5.06e-05	0.00028	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—JUN—sarcoma	5e-05	0.000277	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—HRAS—sarcoma	4.92e-05	0.000272	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ENO2—sarcoma	4.87e-05	0.00027	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CREB1—sarcoma	4.86e-05	0.000269	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—HBA1—sarcoma	4.83e-05	0.000268	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	4.82e-05	0.000267	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—KDR—sarcoma	4.81e-05	0.000266	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—KRAS—sarcoma	4.78e-05	0.000265	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TLE1—sarcoma	4.73e-05	0.000262	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FLT1—sarcoma	4.6e-05	0.000255	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HRAS—sarcoma	4.53e-05	0.000251	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MMP2—sarcoma	4.52e-05	0.00025	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PLCG1—sarcoma	4.52e-05	0.00025	CbGpPWpGaD
Minocycline—IL1B—Immune System—FOXO1—sarcoma	4.49e-05	0.000249	CbGpPWpGaD
Minocycline—IL1B—Immune System—PDGFRB—sarcoma	4.48e-05	0.000248	CbGpPWpGaD
Minocycline—IL1B—Immune System—PDGFRA—sarcoma	4.41e-05	0.000244	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—SRC—sarcoma	4.39e-05	0.000243	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCR4—sarcoma	4.34e-05	0.000241	CbGpPWpGaD
Minocycline—CASP1—Immune System—MDM2—sarcoma	4.31e-05	0.000239	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ATF1—sarcoma	4.29e-05	0.000238	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	4.28e-05	0.000237	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—VEGFA—sarcoma	4.28e-05	0.000237	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—NRAS—sarcoma	4.22e-05	0.000234	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CREB1—sarcoma	4.22e-05	0.000234	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PLCG1—sarcoma	4.13e-05	0.000229	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—HRAS—sarcoma	4.11e-05	0.000228	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TLE1—sarcoma	4.11e-05	0.000228	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—HRAS—sarcoma	4.06e-05	0.000225	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VEGFC—sarcoma	3.99e-05	0.000221	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP2—sarcoma	3.92e-05	0.000217	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL2—sarcoma	3.85e-05	0.000213	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—EGFR—sarcoma	3.85e-05	0.000213	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—SRC—sarcoma	3.81e-05	0.000211	CbGpPWpGaD
Minocycline—CASP1—Immune System—JUN—sarcoma	3.75e-05	0.000208	CbGpPWpGaD
Minocycline—CASP1—Immune System—CTNNB1—sarcoma	3.72e-05	0.000206	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—NRAS—sarcoma	3.67e-05	0.000203	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—KRAS—sarcoma	3.63e-05	0.000201	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—VEGFC—sarcoma	3.47e-05	0.000192	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CTNNB1—sarcoma	3.47e-05	0.000192	CbGpPWpGaD
Minocycline—IL1B—Immune System—KIT—sarcoma	3.42e-05	0.00019	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IGF1R—sarcoma	3.37e-05	0.000187	CbGpPWpGaD
Minocycline—CASP1—Immune System—SRC—sarcoma	3.36e-05	0.000186	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—EGFR—sarcoma	3.34e-05	0.000185	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—sarcoma	3.3e-05	0.000183	CbGpPWpGaD
Minocycline—IL1B—Immune System—CREB1—sarcoma	3.26e-05	0.00018	CbGpPWpGaD
Minocycline—CASP1—Immune System—NRAS—sarcoma	3.23e-05	0.000179	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FOXO1—sarcoma	3.21e-05	0.000178	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PDGFRB—sarcoma	3.2e-05	0.000177	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FLT1—sarcoma	3.19e-05	0.000177	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—KRAS—sarcoma	3.16e-05	0.000175	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PDGFRA—sarcoma	3.15e-05	0.000175	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PLCG1—sarcoma	3.14e-05	0.000174	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—SRC—sarcoma	3.13e-05	0.000174	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—HRAS—sarcoma	3.09e-05	0.000171	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IL2—sarcoma	3.06e-05	0.000169	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—VEGFA—sarcoma	3.05e-05	0.000169	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCR4—sarcoma	3.01e-05	0.000167	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NRAS—sarcoma	3.01e-05	0.000167	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CTNNB1—sarcoma	3.01e-05	0.000167	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ATF1—sarcoma	2.98e-05	0.000165	CbGpPWpGaD
Minocycline—CASP1—Immune System—EGFR—sarcoma	2.95e-05	0.000163	CbGpPWpGaD
Minocycline—CASP1—Immune System—KRAS—sarcoma	2.78e-05	0.000154	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FLT1—sarcoma	2.77e-05	0.000154	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EGFR—sarcoma	2.75e-05	0.000152	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PLCG1—sarcoma	2.72e-05	0.000151	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—SRC—sarcoma	2.72e-05	0.000151	CbGpPWpGaD
Minocycline—IL1B—Immune System—MDM2—sarcoma	2.69e-05	0.000149	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—HRAS—sarcoma	2.68e-05	0.000149	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SRC—sarcoma	2.67e-05	0.000148	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—KDR—sarcoma	2.65e-05	0.000147	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCR4—sarcoma	2.62e-05	0.000145	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NRAS—sarcoma	2.62e-05	0.000145	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—KRAS—sarcoma	2.59e-05	0.000144	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ATF1—sarcoma	2.59e-05	0.000143	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NRAS—sarcoma	2.57e-05	0.000142	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—KIT—sarcoma	2.44e-05	0.000135	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL2—sarcoma	2.41e-05	0.000133	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EGFR—sarcoma	2.38e-05	0.000132	CbGpPWpGaD
Minocycline—CASP1—Immune System—HRAS—sarcoma	2.37e-05	0.000131	CbGpPWpGaD
Minocycline—IL1B—Immune System—JUN—sarcoma	2.34e-05	0.00013	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF1R—sarcoma	2.34e-05	0.00013	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CREB1—sarcoma	2.33e-05	0.000129	CbGpPWpGaD
Minocycline—IL1B—Immune System—CTNNB1—sarcoma	2.32e-05	0.000129	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—KRAS—sarcoma	2.25e-05	0.000125	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FOXO1—sarcoma	2.23e-05	0.000123	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PDGFRB—sarcoma	2.22e-05	0.000123	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—KRAS—sarcoma	2.21e-05	0.000122	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—HRAS—sarcoma	2.2e-05	0.000122	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PDGFRA—sarcoma	2.19e-05	0.000121	CbGpPWpGaD
Minocycline—IL1B—Immune System—SRC—sarcoma	2.1e-05	0.000116	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF1R—sarcoma	2.03e-05	0.000113	CbGpPWpGaD
Minocycline—IL1B—Immune System—NRAS—sarcoma	2.02e-05	0.000112	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—sarcoma	1.96e-05	0.000109	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FOXO1—sarcoma	1.93e-05	0.000107	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PDGFRB—sarcoma	1.93e-05	0.000107	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MDM2—sarcoma	1.92e-05	0.000107	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—HRAS—sarcoma	1.91e-05	0.000106	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PDGFRA—sarcoma	1.9e-05	0.000105	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—HRAS—sarcoma	1.88e-05	0.000104	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KDR—sarcoma	1.84e-05	0.000102	CbGpPWpGaD
Minocycline—IL1B—Immune System—EGFR—sarcoma	1.84e-05	0.000102	CbGpPWpGaD
Minocycline—IL1B—Immune System—KRAS—sarcoma	1.74e-05	9.64e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL2—sarcoma	1.72e-05	9.53e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KIT—sarcoma	1.7e-05	9.4e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCND1—sarcoma	1.68e-05	9.29e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—JUN—sarcoma	1.67e-05	9.27e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CTNNB1—sarcoma	1.66e-05	9.2e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CREB1—sarcoma	1.61e-05	8.95e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KDR—sarcoma	1.6e-05	8.86e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SRC—sarcoma	1.5e-05	8.32e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—HRAS—sarcoma	1.48e-05	8.19e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KIT—sarcoma	1.47e-05	8.16e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VEGFA—sarcoma	1.46e-05	8.1e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NRAS—sarcoma	1.44e-05	8e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CREB1—sarcoma	1.4e-05	7.77e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MYC—sarcoma	1.34e-05	7.45e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MDM2—sarcoma	1.34e-05	7.4e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EGFR—sarcoma	1.32e-05	7.29e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—KRAS—sarcoma	1.24e-05	6.88e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL2—sarcoma	1.19e-05	6.62e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCND1—sarcoma	1.16e-05	6.45e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—JUN—sarcoma	1.16e-05	6.44e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MDM2—sarcoma	1.16e-05	6.43e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CTNNB1—sarcoma	1.15e-05	6.39e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—sarcoma	1.1e-05	6.12e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HRAS—sarcoma	1.06e-05	5.85e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SRC—sarcoma	1.04e-05	5.77e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL2—sarcoma	1.04e-05	5.74e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VEGFA—sarcoma	1.01e-05	5.62e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCND1—sarcoma	1.01e-05	5.6e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—JUN—sarcoma	1.01e-05	5.59e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NRAS—sarcoma	1e-05	5.55e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CTNNB1—sarcoma	1e-05	5.54e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MYC—sarcoma	9.34e-06	5.17e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EGFR—sarcoma	9.13e-06	5.06e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SRC—sarcoma	9.04e-06	5.01e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NRAS—sarcoma	8.7e-06	4.82e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KRAS—sarcoma	8.63e-06	4.78e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MYC—sarcoma	8.1e-06	4.49e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EGFR—sarcoma	7.93e-06	4.39e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—sarcoma	7.67e-06	4.25e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KRAS—sarcoma	7.49e-06	4.15e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HRAS—sarcoma	7.33e-06	4.06e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—sarcoma	6.66e-06	3.69e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HRAS—sarcoma	6.36e-06	3.53e-05	CbGpPWpGaD
